Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Trends in Cancer|April 5, 2024
A big step for MYC-targeted therapiesDanielle F Atibalentja, Anja Deutzmann, Dean W FelsherJournal of Immunology (Baltimore, Md. : 1950)|December 24, 2010
Functional redundancy between thymic CD8α+ and Sirpα+ conventional dendritic cells in presentation of blood-derived lysozyme by MHC class II proteinsDanielle F Atibalentja, Kenneth M Murphy, Emil R UnanueJournal of Immunology (Baltimore, Md. : 1950)|November 26, 2009
Thymus-blood protein interactions are highly effective in negative selection and regulatory T cell inductionDanielle F Atibalentja, Craig A Byersdorfer, Emil R UnanueJCO Precision Oncology|May 30, 2024
Expanding the Reach of Personalized Medicine in Cancer Care: Current Progress and Future Directions of <i>JCO Precision Oncology</i>Yushu Shi, J Bryan Iorgulescu, Stephanie Valladao, et al.Nanotheranostics|February 11, 2022
Anti-PD-L1 F(ab) Conjugated PEG-PLGA Nanoparticle Enhances Immune Checkpoint TherapyChristina K Lee, Danielle F Atibalentja, Lilian E Yao, et al.Cell Chemical Biology|August 13, 2025
Targeting the MYC oncogene with a selective bi-steric mTORC1 inhibitor elicits tumor regression in MYC-driven cancersWadie D Mahauad-Fernandez, Yu Chi Yang, Ian Lai, et al.Pageof 1